-
RNA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Avidity Biosciences (RNA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 372.98 mm | 372.98 mm | 372.98 mm | 372.98 mm | 372.98 mm | 372.98 mm |
Cash burn (monthly) | 68.52 mm | (no burn) | 32.71 mm | 27.06 mm | 21.87 mm | 15.37 mm |
Cash used (since last report) | 291.83 mm | n/a | 139.32 mm | 115.24 mm | 93.15 mm | 65.48 mm |
Cash remaining | 81.15 mm | n/a | 233.67 mm | 257.75 mm | 279.83 mm | 307.50 mm |
Runway (months of cash) | 1.2 | n/a | 7.1 | 9.5 | 12.8 | 20.0 |
13F holders | Current |
---|---|
Total holders | 245 |
Opened positions | 71 |
Closed positions | 24 |
Increased positions | 85 |
Reduced positions | 62 |
13F shares | Current |
---|---|
Total value | 5.21 tn |
Total shares | 132.69 mm |
Total puts | 161.30 k |
Total calls | 223.60 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
FMR | 16.85 mm | $773.86 bn |
T. Rowe Price | 10.63 mm | $488.42 mm |
BlackRock | 9.73 mm | $446.76 bn |
Vanguard | 9.23 mm | $423.79 bn |
RTW Investments | 8.13 mm | $373.54 bn |
Wellington Management | 7.03 mm | $322.93 bn |
Avoro Capital Advisors | 6.88 mm | $315.77 bn |
Ra Capital Management | 6.30 mm | $289.38 bn |
BMY Bristol-Myers Squibb | 5.08 mm | $219.36 mm |
JHG Janus Henderson | 4.90 mm | $224.77 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | Kathleen P. Gallagher | Common Stock | Sell | Dispose S | No | Yes | 32.1563 | 5,875 | 188.92 k | 50,554 |
3 Feb 25 | Kathleen P. Gallagher | Common Stock | Option exercise | Acquire M | No | Yes | 16.65 | 5,875 | 97.82 k | 56,429 |
3 Feb 25 | Kathleen P. Gallagher | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 16.65 | 5,875 | 97.82 k | 34,675 |
22 Jan 25 | Kathleen P. Gallagher | Common Stock | Sell | Dispose S | No | Yes | 30.1609 | 5,629 | 169.78 k | 50,554 |
21 Jan 25 | Steven George Hughes | Common Stock | Sell | Dispose S | No | Yes | 28.5906 | 2,032 | 58.10 k | 82,428 |
21 Jan 25 | Steven George Hughes | Common Stock | Sell | Dispose S | No | Yes | 28.5955 | 1,915 | 54.76 k | 84,460 |
21 Jan 25 | Kathleen P. Gallagher | Common Stock | Sell | Dispose S | No | Yes | 28.593 | 1,817 | 51.95 k | 56,183 |
21 Jan 25 | Kathleen P. Gallagher | Common Stock | Sell | Dispose S | No | Yes | 28.5953 | 670 | 19.16 k | 58,000 |
21 Jan 25 | Kathleen P. Gallagher | Common Stock | Sell | Dispose S | No | Yes | 28.59 | 1,295 | 37.02 k | 58,670 |
21 Jan 25 | Boyce Sarah | Common Stock | Sell | Dispose S | No | Yes | 28.5946 | 5,659 | 161.82 k | 337,411 |